| MD | SB590 | Intro
25% | Altering certain provisions of law prohibiting discrimination based on certain protected characteristics to include prohibitions on discrimination based on sexual orientation, gender identity, race, religious beliefs, marital status, and disability.
[Detail][Text][Discuss] | 2024-04-08
Motion Special Order until Later Today (Senator Simonaire) Adopted |
| MD | HB1270 | Intro
25% | Requiring that the calculation of an enrollee's contribution to a cost sharing requirement for a prescription drug be based on the list price of the drug reduced by at least 85% of the total amount of rebates received or expected to be received by th...
[Detail][Text][Discuss] | 2024-03-16
Withdrawn by Sponsor |
| MD | HB1331 | Intro
25% | Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for massage therapy; and prohibiting the insurers, nonprofit health service plans, and health maintenance organizations from imposing...
[Detail][Text][Discuss] | 2024-03-13
Withdrawn by Sponsor |
| MD | SB497 | Intro
25% | Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal...
[Detail][Text][Discuss] | 2024-03-04
Withdrawn by Sponsor |
| MD | HB1423 | Intro
25% | Prohibiting the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations from applying a prior authorization requirement, step therapy protocol, or fail...
[Detail][Text][Discuss] | 2024-03-04
Withdrawn by Sponsor |
| MD | HB736 | Intro
25% | Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal...
[Detail][Text][Discuss] | 2024-02-26
Withdrawn by Sponsor |
| MD | HB240 | Intro
25% | Prohibiting a carrier from canceling an individual health benefit plan if a policyholder has made a premium payment before the end of the grace period, the amount of the premium payment made is less than the aggregate amount of the net monthly premiu...
[Detail][Text][Discuss] | 2024-02-19
Withdrawn by Sponsor |
| MD | SB227 | Intro
25% | Prohibiting a carrier from canceling an individual health benefit plan if a policyholder has made a premium payment before the end of the grace period, the amount of the premium payment made is less than the aggregate amount of the net monthly premiu...
[Detail][Text][Discuss] | 2024-02-19
Withdrawn by Sponsor |
| MD | HB1412 | Intro
25% | Establishing the Abortion Care Access Grant Program to provide grants to improve access to abortion care services for individuals in the State; establishing the Abortion Care Access Grant Program Fund as a special, nonlapsing fund to provide grants u...
[Detail][Text][Discuss] | 2024-02-15
To House Health and Government Operations Committee |
| MD | HB1376 | Intro
25% | Requiring the Maryland Medical Assistance Program and certain health insurers, nonprofit health service plans, managed care organizations, and health maintenance organizations to provide coverage and certain reimbursement for a special administrative...
[Detail][Text][Discuss] | 2024-02-13
To House Health and Government Operations Committee |
| MD | HB880 | Intro
25% | Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are required to reimb...
[Detail][Text][Discuss] | 2024-02-09
To House Health and Government Operations Committee |
| MD | HB1085 | Intro
25% | Altering certain reporting requirements on health insurance carriers relating to compliance with the federal Mental Health Parity and Addiction Equity Act; altering requirements for certain analyses of nonquantitative treatment limitations required o...
[Detail][Text][Discuss] | 2024-02-09
To House Health and Government Operations Committee |
| MD | HB1137 | Intro
25% | Requiring the Maryland Medical Assistance Program and insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations to provide coverage for calcium score testing for individuals who have at least three of ...
[Detail][Text][Discuss] | 2024-02-09
To House Health and Government Operations Committee |
| MD | HB1351 | Intro
25% | Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide certain coverage for the full length of long-term antibiotic treatment of Lyme disease and related tick-borne illnesses under certain circumst...
[Detail][Text][Discuss] | 2024-02-09
To House Health and Government Operations Committee |
| MD | HB1368 | Intro
25% | Prohibiting certain health insurance entities from taking certain actions with respect to the dispensing of clinician-administered drugs and related services; and authorizing certain health insurance entities to allow the use of a certain pharmacy or...
[Detail][Text][Discuss] | 2024-02-09
To House Health and Government Operations Committee |
| MD | HB1283 | Intro
25% | Prohibiting discrimination based on an individual's sexual orientation or gender identity by an insurer, an insurance producer, a surety insurer, and a health network when engaging in certain insurance-related business practices.
[Detail][Text][Discuss] | 2024-02-09
To House Economic Matters Committee |
| MD | SB1019 | Intro
25% | Requiring that the calculation of an enrollee's contribution to a cost sharing requirement for a prescription drug be based on the list price of the drug reduced by at least 85% of the total amount of rebates received or expected to be received by th...
[Detail][Text][Discuss] | 2024-02-06
To Senate Finance Committee |
| MD | SB1021 | Intro
25% | Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are required to reimb...
[Detail][Text][Discuss] | 2024-02-06
To Senate Finance Committee |
| MD | SB947 | Intro
25% | Establishing the Abortion Care Access Grant Program to provide grants to improve access to abortion care services for individuals in the State; establishing the Abortion Care Access Grant Program Fund as a special, nonlapsing fund to provide grants u...
[Detail][Text][Discuss] | 2024-02-06
To Senate Finance Committee |
| MD | SB989 | Intro
25% | Requiring insurers, nonprofit health service plans, and health maintenance organizations to limit the amount a covered individual is required to pay in copayments, coinsurance, and deductibles for a covered prescription epinephrine injector to not mo...
[Detail][Text][Discuss] | 2024-02-06
To Senate Finance Committee |
| MD | SB990 | Intro
25% | Prohibiting the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations from applying a prior authorization requirement, step therapy protocol, or fail...
[Detail][Text][Discuss] | 2024-02-06
To Senate Finance Committee |
| MD | HB110 | Intro
25% | Requiring that certain criteria and standards used by private review agents for health insurance utilization review relating to mental health and substance use disorder benefits meet certain requirements; requiring a private review agent to take cert...
[Detail][Text][Discuss] | 2024-02-05
Withdrawn by Sponsor |
| MD | HB939 | Intro
25% | Requiring insurers, nonprofit health service plans, and health maintenance organizations to limit the amount a covered individual is required to pay in copayments, coinsurance, and deductibles for a covered prescription epinephrine injector to not mo...
[Detail][Text][Discuss] | 2024-02-05
To House Health and Government Operations Committee |
| MD | SB93 | Intro
25% | Requiring that certain criteria and standards used by private review agents for health insurance utilization review relating to mental health and substance use disorder benefits meet certain requirements; requiring a private review agent to take cert...
[Detail][Text][Discuss] | 2024-02-02
To Senate Finance Committee |
| MD | SB626 | Intro
25% | Altering the definition of "purchaser" for the purpose of certain provisions of State insurance law governing pharmacy benefits managers to exclude certain nonprofit health maintenance organizations; and repealing certain provisions that restrict app...
[Detail][Text][Discuss] | 2024-02-02
To Senate Finance Committee |
| MD | SB754 | Intro
25% | Prohibiting certain health insurance entities from taking certain actions with respect to the dispensing of clinician-administered drugs and related services; and authorizing certain health insurance entities to allow the use of a certain pharmacy or...
[Detail][Text][Discuss] | 2024-02-02
To Senate Finance Committee |
| MD | HB400 | Intro
25% | Requiring the Maryland Medical Assistance Program and certain health insurers, nonprofit health service plans, and health maintenance organizations to provide coverage and certain reimbursement for annual behavioral health wellness visits; and applyi...
[Detail][Text][Discuss] | 2024-01-26
To House Health and Government Operations Committee |
| MD | SB124 | Intro
25% | Requiring the Maryland Medical Assistance Program and certain health insurers, nonprofit health service plans, and health maintenance organizations to provide coverage and certain reimbursement for annual behavioral health wellness visits.
[Detail][Text][Discuss] | 2024-01-24
To Senate Finance Committee |
| MD | SB535 | Intro
25% | Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for labor and delivery services without certain cost-sharing requirements.
[Detail][Text][Discuss] | 2024-01-24
To Senate Finance Committee |
| MD | SB526 | Intro
25% | Prohibiting certain pharmacy benefits managers from requiring a beneficiary to use a specific pharmacy or entity for a specialty drug if the drug is dispensed by a physician, used in the treatment of a certain condition, and meets other requirements;...
[Detail][Text][Discuss] | 2024-01-24
To Senate Finance Committee |
